Society ❯ Healthcare

Patient Care

Chronic Illness Treatment Options Access to Healthcare Insurance Issues Labor Issues Forensic Psychiatry Medical Workforce Allergy Patient Care Negligence Ethics in Medicine Personalized Medicine Early Diagnosis Support Networks Emergency Services Organ Transplantation Quality of Care Transplantation Clinical Trials Amputation Treatment Insurance Practices Mental Health Solutions Access to Medication Infants Innovative Therapies Healthcare Workers Vision Impairment Transformational Medicines Impact of Strikes Aged Care Patients Surgical Interventions Medical Education Rehabilitation Waiting Times Neurological Care

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Genmab will launch a fully financed $97-per-share tender offer with closing targeted for early 2026.

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

Medicare to Test AI-Screened Prior Authorization in Six States Starting in 2026

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

Implantable Nerve Stimulator Shows Breakthrough in Spinal Cord Injury Recovery